Browsing by Author Zheng, Kanglian
Showing results 1 to 3 of 3
Issue Date | Title | Author(s) |
2022 | Different interventional time of hepatic arterial infusion with PD-1 inhibitor for advanced biliary tract cancer: a multicenter retrospective study | Zhang, Ting; Yang, Xu; Yang, Xiaobo; Zheng, Kanglian; Wang, Yanyu; Wang, Yunchao; Sang, Xinting; Lu, Xin; Xu, Yiyao; Wang, Xiaodong; Zhao, Haitao |
14-Mar-2022 | Signal enhancement ratio of CE-MRI: a potential biomarker of survival after hepatic arterial infusion chemotherapy in biliary tract cancers | Zheng, Kanglian; Fu, Shijie; Leng, Boyu; Cui, Yong; Yang, Renjie; Cao, Guang; Xu, Liang; Li, Wen-Qing; Li, Ying; Zhu, Xu; Gao, Song; Liu, Peng; Wang, Xiaodong |
May-2022 | Sorafenib Plus Hepatic ArterialInfusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized TriaL | Zheng, Kanglian; Zhu, Xu; Fu, Shijie; Cao, Guang; Li, Wen-Qing; Xu, Liang; Chen, Hui; Wu, Di; Yang, Renjie; Wang, Kun; Liu, Wei; Wang, Hongwei; Bao, Quan; Liu, Ming; Hao, Chunyi; Shen, Lin; Xing, Baocai; Wang, Xiaodong |